Caractérisation et comparaison des propriétés immunostimulantes de nanoparticules biodégradables de poly(acide lactique) et de chitosane après adsorption de TLR ligands ou d’antigènes du VIH1

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-12-10

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards designer microparticles: simultaneous control of anisotropy, shape, and size.

  2010cited by this paper
• Influence of the chitosan nature on the transfection efficacy of DNA-loaded nanoparticles after hydrodynamic administration in mice

  2010cited by this paper
• Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications

  2010cited by this paper
• Polymeric particles in vaccine delivery.

  2010cited by this paper
• Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

  2010cited by this paper
• Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.

  2009cited by this paper
• Trimethyl chitosan and its applications in drug delivery

  2009cited by this paper
• Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.

  2009cited by this paper
• All‐trans retinoic acid potentiates the antibody response in mice to a lipopeptide antigen adjuvanted with liposomal lipid A

  2009cited by this paper
• Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy

  2009cited by this paper
• Mechanism of action of licensed vaccine adjuvants.

  2009cited by this paper
• Polysaccharide-based vaccine delivery systems: Macromolecular assembly, interactions with antigen presenting cells, and in vivo immunomonitoring.

  2009cited by this paper
• Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles

  2009cited by this paper
• NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

  2009influential reference
• Chitosan/sodium tripolyphosphate nanoparticles: preparation, characterization and application as drug carrier.

  2009cited by this paper
• Nanoparticles for nasal vaccination.

  2009cited by this paper
• Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study

  2009cited by this paper
• Nanocarriers’ entry into the cell: relevance to drug delivery

  2009cited by this paper
• In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines.

  2009cited by this paper
• Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

  2009cited by this paper
• Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.

  2009cited by this paper
• Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1

  2009cited by this paper
• Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.

  2009cited by this paper
• Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

  2008cited by this paper
• Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates

  2008cited by this paper
• Challenges in the development of an HIV-1 vaccine

  2008cited by this paper
• Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

  2008cited by this paper
• Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

  2008cited by this paper
• Poly(γ‐glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: Potential for an AIDS vaccine

  2008cited by this paper
• Clinical investigations of Toll-like receptor agonists.

  2008cited by this paper
• Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

  2008cited by this paper
• Towards biocompatible vaccine delivery systems: interactions of colloidal PECs based on polysaccharides with HIV-1 p24 antigen.

  2008cited by this paper
• Design opportunities for actively targeted nanoparticle vaccines.

  2008cited by this paper
• Targeting the porcine immune system—Particulate vaccines in the 21st century

  2008cited by this paper
• Poly (Lactide-co-Glycolide) Microspheres in Respirable Sizes Enhance an In Vitro T Cell Response to Recombinant Mycobacterium tuberculosis Antigen 85B

  2007cited by this paper
• VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection

  2007cited by this paper
• Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

  2007cited by this paper
• Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits.

  2007cited by this paper
• Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.

  2007cited by this paper
• Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.

  2007cited by this paper
• Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

  2007cited by this paper
• Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

  2007cited by this paper
• [mRNA-transfected dendritic cells: a promising strategy in immunotherapy].

  2007cited by this paper
• Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity

  2007cited by this paper
• Pathogen recognition and development of particulate vaccines: does size matter?

  2006cited by this paper
• Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

  2006cited by this paper
• A review of vaccine research and development: the human immunodeficiency virus (HIV).

  2006cited by this paper
• [Innate immunity: cutaneous expression of Toll-like receptors].

  2006cited by this paper
• Etude de la dynamique moléculaire au site de contact entre les lymphocytes T et les cellules présentatrices de l'antigène

  2006cited by this paper
• Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity.

  2006cited by this paper
• Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.

  2006cited by this paper
• In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system

  2006cited by this paper
• Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites

  2006cited by this paper
• An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection

  2006cited by this paper
• SPL7013 Gel as a Topical Microbicide for Prevention of Vaginal Transmission of SHIV89.6P in Macaques

  2005cited by this paper
• TLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements*♦

  2005influential reference
• In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegative Window Period through 30 Months Postinfection

  2005cited by this paper
• Induction of dendritic cell‐mediated immune responses against HIV‐1 by antigen‐capturing nanospheres in mice

  2005cited by this paper
• Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen.

  2005cited by this paper
• Toll-like receptors.

  2005cited by this paper
• Differential levels of dendritic cell maturation on different biomaterials used in combination products.

  2005cited by this paper
• Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod1

  2005cited by this paper
• A novel CD4–CD8α+CD205+CD11b– murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis

  2005cited by this paper
• Differentiation of CD8 T cells in response to acute and chronic viral infections: implications for HIV vaccine development.

  2005cited by this paper
• Adsorption of chitosan onto poly(D,L-lactic acid) particles : A physico-chemical investigation

  2005cited by this paper
• Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner

  2005cited by this paper
• Nanoparticles for gene delivery to retinal pigment epithelial cells.

  2005cited by this paper
• Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent

  2005cited by this paper
• The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years.

  2005influential reference
• mRNA Is an Endogenous Ligand for Toll-like Receptor 3*

  2004cited by this paper
• Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen

  2004cited by this paper
• Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect

  2004cited by this paper
• Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.

  2004cited by this paper
• Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

  2004cited by this paper
• Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL*

  2004cited by this paper
• Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments.

  2004cited by this paper
• Functions of toll-like receptors: lessons from KO mice.

  2004cited by this paper
• Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• Induction of HIV‐specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV‐capturing nanospheres in macaques

  2004influential reference
• Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA

  2004cited by this paper
• Chitosan-based gastrointestinal delivery systems.

  2003cited by this paper
• Chitosane : comportement en solution et formation de particules

  2003cited by this paper
• Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.

  2003cited by this paper
• HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses1

  2003cited by this paper
• New hope for AIDS vaccine.

  2003cited by this paper
• Hide, shield and strike back: how HIV-infected cells avoid immune eradication

  2003cited by this paper
• Role of adapters in Toll-like receptor signalling.

  2003cited by this paper
• Leucine-rich repeats and pathogen recognition in Toll-like receptors.

  2003cited by this paper
• N-Trimethyl Chitosan Chloride: Optimum Degree of Quaternization for Drug Absorption Enhancement Across Epithelial Cells

  2003cited by this paper
• Toll-like receptors: key mediators of microbe detection.

  2002cited by this paper
• The challenge of viral reservoirs in HIV-1 infection.

  2002cited by this paper
• Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines

  2002cited by this paper
• Initial steps of HIV transmission at mucosal sites

  2002cited by this paper
• Innate immune recognition.

  2002cited by this paper
• Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.

  2002cited by this paper
• HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus

  2002cited by this paper
• Potential AIDS vaccine?

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• The mucosal immune system: primary target for HIV infection and AIDS.

  2001cited by this paper

• No citing papers are available for this paper.